Inspira Therapeutics is developing state-of-the-art, tolerizing therapies that ‘retrain’ the host’s immune system to ‘accept’ misdirected targets of autoimmune destruction, thereby halting or reversing some of the most pernicious, debilitating autoimmune diseases.
